Calcium and bone metabolism disorders during pregnancy and lactation

Endocrinology and Metabolism Clinics of North America

Volumn 40, Issue 4, 2011, Pages 795-826

  Kovacs, Christopher S ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Fetus; Hypoparathyroidism; Lactation; Neonate; Parathyroid hormone related protein; Pregnancy; Primary hyperparathyroidism; Pseudohypoparathyroidism; Vitamin D deficiency

Indexed keywords

ALBUMIN; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; CINACALCET; CISPLATIN; COLECALCIFEROL; ESTROGEN; ETOPOSIDE; FUROSEMIDE; MAGNESIUM; MAGNESIUM SULFATE; MITHRAMYCIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE[1-34]; PHOSPHATE; PLACEBO; TESTOSTERONE; VITAMIN D;

ADAPTATION; BONE METABOLISM; CALCANEUS FRACTURE; CALCIUM ABSORPTION; CALCIUM EXCRETION; CALCIUM INTAKE; CALCIUM METABOLISM; CONGENITAL HYPOTHYROIDISM; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG MEGADOSE; ECLAMPSIA; FAMILIAL BENIGN HYPOCALCIURIC HYPERCALCEMIA; FETUS OUTCOME; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; HYPOPHOSPHATEMIC RICKETS; HYPOTHYROIDISM; INTESTINE ABSORPTION; KYPHOPLASTY; LACTATION; LOADING DRUG DOSE; METABOLIC DISORDER; OSTEOPOROSIS; OVARY CARCINOMA; PARATHYROIDECTOMY; PATHOGENESIS; PERCUTANEOUS VERTEBROPLASTY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECONDARY HYPERPARATHYROIDISM; URINARY EXCRETION; VITAMIN D DEFICIENCY;

BONE AND BONES; BONE DISEASES; CALCIUM; CALCIUM, DIETARY; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; INFANT, NEWBORN; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; VITAMIN D DEFICIENCY;

EID: 82855166085     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2011.08.002     Document Type: Review

References (244)

1. Kovacs C.S., Kronenberg H.M. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocr Rev 1997, 18:832-872.
2. Kovacs C.S. Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am J Clin Nutr 2008, 88(2):520S-528S.
3. Kovacs CS. Fetus, neonate and infant. In: Feldman D, Pike WJ, Adams JS, editors. Vitamin D. 3rd edition. New York: Academic Press. p. 625-46.
4. Givens M.H., Macy I.C. The chemical composition of the human fetus. J Biol Chem 1933, 102:7-17.
5. Trotter M., Hixon B.B. Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 1974, 179:1-18.
6. Widdowson E.M., Dickerson J.W. Chemical composition of the body. Mineral metabolism: an advanced treatise, Volume II, The Elements, Part A 1964, 1-247. Academic Press, New York. C.L. Comar, F. Bronner (Eds.).
7. Dahlman T., Sjoberg H.E., Bucht E. Calcium homeostasis in normal pregnancy and puerperium. A longitudinal study. Acta Obstet Gynecol Scand 1994, 73:393-398.
8. Gallacher S.J., Fraser W.D., Owens O.J., et al. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 1994, 131:369-374.
9. Cross N.A., Hillman L.S., Allen S.H., et al. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 1995, 61:514-523.
10. Rasmussen N., Frolich A., Hornnes P.J., et al. Serum ionized calcium and intact parathyroid hormone levels during pregnancy and postpartum. Br J Obstet Gynaecol 1990, 97:857-859.
11. Seki K., Makimura N., Mitsui C., et al. Calcium-regulating hormones and osteocalcin levels during pregnancy: a longitudinal study. Am J Obstet Gynecol 1991, 164:1248-1252.
12. Singh H.J., Mohammad N.H., Nila A. Serum calcium and parathormone during normal pregnancy in Malay women. J Matern Fetal Med 1999, 8(3):95-100.
13. Kovacs C.S. Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 2001, 86(6):2344-2348.
14. Turner M., Barre P.E., Benjamin A., et al. Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy?. Miner Electrolyte Metab 1988, 14:246-252.
15. Woodrow J.P., Sharpe C.J., Fudge N.J., et al. Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 2006, 147:4010-4021.
16. Horwitz M.J., Tedesco M.B., Sereika S.M., et al. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36). J Clin Endocrinol Metab 2003, 88(4):1603-1609.
17. Horwitz M.J., Tedesco M.B., Sereika S.M., et al. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res 2005, 20(10):1792-1803.
18. Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J 2008, 55(6):959-966.
19. Kovacs C.S., Lanske B., Hunzelman J.L., et al. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A 1996, 93:15233-15238.
20. Care A.D., Abbas S.K., Pickard D.W., et al. Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein. Exp Physiol 1990, 75:605-608.
21. Cornish J., Callon K.E., Nicholson G.C., et al. Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo. Endocrinology 1997, 138:1299-1304.
22. Fenton A.J., Kemp B.E., Hammonds R.G., et al. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinology 1991, 129:3424-3426.
23. Fenton A.J., Kemp B.E., Kent G.N., et al. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology 1991, 129:1762-1768.
24. Heaney R.P., Skillman T.G. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 1971, 33:661-670.
25. Halloran B.P., DeLuca H.F. Calcium transport in small intestine during pregnancy and lactation. Am J Physiol 1980, 239:E64-E68.
26. Brommage R., Baxter D.C., Gierke L.W. Vitamin D-independent intestinal calcium and phosphorus absorption during reproduction. Am J Physiol 1990, 259:G631-G638.
27. Fudge N.J., Kovacs C.S. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology 2010, 151(3):886-895.
28. Pahuja D.N., DeLuca H.F. Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in vitamin D-deficient rats. Science 1981, 214:1038-1039.
29. Mainoya J.R. Effects of bovine growth hormone, human placental lactogen and ovine prolactin on intestinal fluid and ion transport in the rat. Endocrinology 1975, 96:1165-1170.
30. Purdie D.W., Aaron J.E., Selby P.L. Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 1988, 95(9):849-854.
31. Naylor K.E., Iqbal P., Fledelius C., et al. The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 2000, 15(1):129-137.
32. Black A.J., Topping J., Durham B., et al. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 2000, 15(3):557-563.
33. Ritchie L.D., Fung E.B., Halloran B.P., et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 1998, 67(4):693-701.
34. Ulrich U., Miller P.B., Eyre D.R., et al. Bone remodeling and bone mineral density during pregnancy. Arch Gynecol Obstet 2003, 268(4):309-316.
35. Kaur M., Pearson D., Godber I., et al. Longitudinal changes in bone mineral density during normal pregnancy. Bone 2003, 32(4):449-454.
36. Gambacciani M., Spinetti A., Gallo R., et al. Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. Am J Obstet Gynecol 1995, 173:890-893.
37. Pearson D., Kaur M., San P., et al. Recovery of pregnancy mediated bone loss during lactation. Bone 2004, 34(3):570-578.
38. To W.W., Wong M.W., Leung T.W. Relationship between bone mineral density changes in pregnancy and maternal and pregnancy characteristics: a longitudinal study. Acta Obstet Gynecol Scand 2003, 82(9):820-827.
39. Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 1996, 11:1052-1060.
40. Paton L.M., Alexander J.L., Nowson C.A., et al. Pregnancy and lactation have no long-term deleterious effect on measures of bone mineral in healthy women: a twin study. Am J Clin Nutr 2003, 77(3):707-714.
41. Dobnig H., Kainer F., Stepan V., et al. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 1995, 80:3699-3707.
42. Yamamoto M., Duong L.T., Fisher J.E., et al. Suckling-mediated increases in urinary phosphate and 3',5'-cyclic adenosine monophosphate excretion in lactating rats: possible systemic effects of parathyroid hormone-related protein. Endocrinology 1991, 129:2614-2622.
43. VanHouten J.N., Dann P., Stewart A.F., et al. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 2003, 112(9):1429-1436.
44. Khosla S., van Heerden J.A., Gharib H., et al. Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 1990, 322:1157. [letter].
45. Kovacs C.S., Chik C.L. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 1995, 80:3036-3042.
46. Sowers M.F., Hollis B.W., Shapiro B., et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. J Am Med Assoc 1996, 276:549-554.
47. Hurley D.L., Tiegs R.D., Wahner H.W., et al. Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 1987, 317(9):537-541.
48. Gonzalez D.C., Mautalen C.A., Correa P.H., et al. Bone mass in totally thyroidectomized patients. Role of calcitonin deficiency and exogenous thyroid treatment. Acta Endocrinol (Copenh) 1991, 124(5):521-525.
49. Giannini S., Nobile M., Sartori L., et al. Bone density and mineral metabolism in thyroidectomized patients treated with long-term L-thyroxine. Clin Sci (Lond) 1994, 87(5):593-597.
50. Nguyen T.T., Heath H., Bryant S.C., et al. Fractures after thyroidectomy in men: a population-based cohort study. J Bone Miner Res 1997, 12(7):1092-1099.
51. Mirzaei S., Krotla G., Knoll P., et al. Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med Austriaca 1999, 26(1):29-31.
52. Bucht E., Telenius-Berg M., Lundell G., et al. Immunoextracted calcitonin in milk and plasma from totally thyroidectomized women. Evidence of monomeric calcitonin in plasma during pregnancy and lactation. Acta Endocrinol (Copenh) 1986, 113:529-535.
53. Balabanova S., Kruse B., Wolf A.S. Calcitonin secretion by human placental tissue. Acta Obstet Gynecol Scand 1987, 66(4):323-326.
54. Ren Y., Chien J., Sun Y.P., et al. Calcitonin is expressed in gonadotropes of the anterior pituitary gland: its possible role in paracrine regulation of lactotrope function. J Endocrinol 2001, 171(2):217-228.
55. Laskey M.A., Prentice A. Effect of pregnancy on recovery of lactational bone loss. Lancet 1997, 349:1518-1519. [letter].
56. Cross N.A., Hillman L.S., Allen S.H., et al. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Miner Res 1995, 10:1312-1320.
57. Kalkwarf H.J., Specker B.L., Bianchi D.C., et al. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 1997, 337(8):523-528.
58. Polatti F., Capuzzo E., Viazzo F., et al. Bone mineral changes during and after lactation. Obstet Gynecol 1999, 94(1):52-56.
59. Kolthoff N., Eiken P., Kristensen B., et al. Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 1998, 94(4):405-412.
60. Laskey M.A., Prentice A., Hanratty L.A., et al. Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin D-receptor genotype. Am J Clin Nutr 1998, 67(4):685-692.
61. VanHouten J.N., Wysolmerski J.J. Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 2003, 144(12):5521-5529.
62. Kelly T.R. Primary hyperparathyroidism during pregnancy. Surgery 1991, 110(6):1028-1033. [discussion: 1033-4].
63. Haenel L.C., Mayfield R.K. Primary hyperparathyroidism in a twin pregnancy and review of fetal/maternal calcium homeostasis. Am J Med Sci 2000, 319(3):191-194.
64. Wermers R.A., Khosla S., Atkinson E.J., et al. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997, 126(6):433-440.
65. Heath H., Hodgson S.F., Kennedy M.A. Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 1980, 302(4):189-193.
66. Kort K.C., Schiller H.J., Numann P.J. Hyperparathyroidism and pregnancy. Am J Surg 1999, 177(1):66-68.
67. Schnatz P.F., Curry S.L. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv 2002, 57(6):365-376.
68. El-Hajj Fuleihan G. Pathogenesis and etiology of primary hyperparathyroidism. UpToDate 13.1 2005, UpToDate, Wellesley (MA). B.D. Rose (Ed.).
69. Kristoffersson A., Dahlgren S., Lithner F., et al. Primary hyperparathyroidism in pregnancy. Surgery 1985, 97(3):326-330.
70. Shangold M.M., Dor N., Welt S.I., et al. Hyperparathyroidism and pregnancy: a review. Obstet Gynecol Surv 1982, 37:217-228.
71. Croom R.D., Thomas C.G. Primary hyperparathyroidism during pregnancy. Surgery 1984, 96(6):1109-1118.
72. Krysiak R., Wilk M., Okopien B. Recurrent pancreatitis induced by hyperparathyroidism in pregnancy. Arch Gynecol Obstet 2011, 284(3):531-534.
73. Clark D., Seeds J.W., Cefalo R.C. Hyperparathyroid crisis and pregnancy. Am J Obstet Gynecol 1981, 140(7):840-842.
74. Carella M.J., Gossain V.V. Hyperparathyroidism and pregnancy: case report and review. J Gen Intern Med 1992, 7:448-453.
75. Inabnet W.B., Baldwin D., Daniel R.O., et al. Hyperparathyroidism and pancreatitis during pregnancy. Surgery 1996, 119(6):710-713.
76. Matthias G.S., Helliwell T.R., Williams A. Postpartum hyperparathyroid crisis. Case report. Br J Obstet Gynaecol 1987, 94(8):807-810.
77. Salem R., Taylor S. Hyperparathyroidism in pregnancy. Br J Surg 1979, 66(9):648-650.
78. Nilsson I.L., Adner N., Reihner E., et al. Primary hyperparathyroidism in pregnancy: a diagnostic and therapeutic challenge. J Womens Health (Larchmt) 2010, 19(6):1117-1121.
79. Negishi H., Kobayashi M., Nishida R., et al. Primary hyperparathyroidism and simultaneous bilateral fracture of the femoral neck during pregnancy. J Trauma 2002, 52(2):367-369.
80. Hess H.M., Dickson J., Fox H.E. Hyperfunctioning parathyroid carcinoma presenting as acute pancreatitis in pregnancy. J Reprod Med 1980, 25(2):83-87.
81. Wagner G., Transhol L., Melchior J.C. Hyperparathyroidism and pregnancy. Acta Endocrinol (Copenh) 1964, 47:549-564.
82. Ludwig G.D. Hyperparathyroidism in relation to pregnancy. N Engl J Med 1962, 267:637-642.
83. Delmonico F.L., Neer R.M., Cosimi A.B., et al. Hyperparathyroidism during pregnancy. Am J Surg 1976, 131:328-337.
84. Ip P. Neonatal convulsion revealing maternal hyperparathyroidism: an unusual case of late neonatal hypoparathyroidism. Arch Gynecol Obstet 2003, 268(3):227-229.
85. Bruce J., Strong J.A. Maternal hyperparathyroidism and parathyroid deficiency in the child, with account of effect of parathyroidectomy on renal function, and of attempt to transplant part of tumor. Q J Med 1955, 24:307-319.
86. Bilezikian J.P., Khan A.A., Potts J.T. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 2009, 94(2):335-339.
87. Schnatz P.F. Surgical treatment of primary hyperparathyroidism during the third trimester. Obstet Gynecol 2002, 99(5 Pt 2):961-963.
88. Norman J., Politz D. Prospective study in 3,000 consecutive parathyroid operations demonstrates 18 objective factors that influence the decision for unilateral versus bilateral surgical approach. J Am Coll Surg 2010, 211(2):244-249.
89. Pothiwala P., Levine S.N. Parathyroid surgery in pregnancy: review of the literature and localization by aspiration for parathyroid hormone levels. J Perinatol 2009, 29(12):779-784.
90. Horjus C., Groot I., Telting D., et al. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab 2009, 22(8):741-749.
91. Patlas N., Golomb G., Yaffe P., et al. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 1999, 60(2):68-73.
92. Mastaglia S.R., Watman N.P., Oliveri B. Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health. Osteoporos Int 2010, 21(11):1959-1962.
93. Djokanovic N., Klieger-Grossmann C., Koren G. Does treatment with bisphosphonates endanger the human pregnancy?. J Obstet Gynaecol Can 2008, 30(12):1146-1148.
94. Levy S., Fayez I., Taguchi N., et al. Pregnancy outcome following in utero exposure to bisphosphonates. Bone 2009, 44(3):428-430.
95. Kovacs C.S., Chafe L.L., Woodland M.L., et al. Calcitropic gene expression suggests a role for intraplacental yolk sac in maternal-fetal calcium exchange. Am J Physiol Endocrinol Metab 2002, 282(3):E721-E732.
96. Kovacs C.S., Ho-Pao C.L., Hunzelman J.L., et al. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 1998, 101:2812-2820.
97. Fudge N.J., Kovacs C.S. Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo. BMC Physiol 2004, 4:5.
98. Rajala B., Abbasi R.A., Hutchinson H.T., et al. Acute pancreatitis and primary hyperparathyroidism in pregnancy: treatment of hypercalcemia with magnesium sulfate. Obstet Gynecol 1987, 70(3 Pt 2):460-462.
99. Dahan M., Chang R.J. Pancreatitis secondary to hyperparathyroidism during pregnancy. Obstet Gynecol 2001, 98(5 Pt 2):923-925.
100. Loughead J.L., Mimouni F., Tsang R.C. Serum ionized calcium concentrations in normal neonates. Am J Dis Child 1988, 142:516-518.
101. Schauberger C.W., Pitkin R.M. Maternal-perinatal calcium relationships. Obstet Gynecol 1979, 53:74-76.
102. David L., Anast C.S. Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, sick, and hypocalcemic newborns. J Clin Invest 1974, 54:287-296.
103. Pieringer H., Hatzl-Griesenhofer M., Shebl O., et al. Hypocalcemic tetany in the newborn as a manifestation of unrecognized maternal primary hyperparathyroidism. Wien Klin Wochenschr 2007, 119(3-4):129-131.
104. McDonnell C.M., Zacharin M.R. Maternal primary hyperparathyroidism: discordant outcomes in a twin pregnancy. J Paediatr Child Health 2006, 42(1-2):70-71.
105. Tsang R.C., Chen I., Friedman M.A., et al. Parathyroid function in infants of diabetic mothers. J Pediatr 1975, 86:399-404.
106. Mehta K.C., Kalkwarf H.J., Mimouni F., et al. Randomized trial of magnesium administration to prevent hypocalcemia in infants of diabetic mothers. J Perinatol 1998, 18(5):352-356.
107. Brown E.M. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem 2007, 45:139-167.
108. Powell B.R., Buist N.R. Late presenting, prolonged hypocalcemia in an infant of a woman with hypocalciuric hypercalcemia. Clin Pediatr (Phila) 1990, 29:241-243.
109. Thomas B.R., Bennett J.D. Symptomatic hypocalcemia and hypoparathyroidism in two infants of mothers with hyperparathyroidism and familial benign hypercalcemia. J Perinatol 1995, 15:23-26.
110. VanHouten J., Dann P., McGeoch G., et al. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 2004, 113(4):598-608.
111. Ardeshirpour L., Dann P., Pollak M., et al. The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland. Bone 2006, 38(6):787-793.
112. Sweeney L.L., Malabanan A.O., Rosen H. Decreased calcitriol requirement during pregnancy and lactation with a window of increased requirement immediately post partum. Endocr Pract 2010, 16(3):459-462.
113. Callies F., Arlt W., Scholz H.J., et al. Management of hypoparathyroidism during pregnancy-report of twelve cases. Eur J Endocrinol 1998, 139(3):284-289.
114. Landing B.H., Kamoshita S. Congenital hyperparathyroidism secondary to maternal hypoparathyroidism. J Pediatr 1970, 77:842-847.
115. Taussig H.B. Possible injury to the cardiovascular system from vitamin D. Ann Intern Med 1966, 65(6):1195-1200.
116. Friedman W.F., Mills L.F. The relationship between vitamin D and the craniofacial and dental anomalies of the supravalvular aortic stenosis syndrome. Pediatrics 1969, 43(1):12-18.
117. Salle B.L., Berthezene F., Glorieux F.H., et al. Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab 1981, 52:810-813.
118. Sadeghi-Nejad A., Wolfsdorf J.I., Senior B. Hypoparathyroidism and pregnancy. Treatment with calcitriol. J Am Med Assoc 1980, 243:254-255.
119. Mather K.J., Chik C.L., Corenblum B. Maintenance of serum calcium by parathyroid hormone-related peptide during lactation in a hypoparathyroid patient. J Clin Endocrinol Metab 1999, 84(2):424-427.
120. Caplan R.H., Beguin E.A. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol 1990, 76:485-489.
121. Shomali M.E., Ross D.S. Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation. Endocr Pract 1999, 5(4):198-200.
122. Breslau N.A., Zerwekh J.E. Relationship of estrogen and pregnancy to calcium homeostasis in pseudohypoparathyroidism. J Clin Endocrinol Metab 1986, 62:45-51.
123. O'Donnell D., Costa J., Meyers A.M. Management of pseudohypoparathyroidism in pregnancy. Case report. Br J Obstet Gynaecol 1985, 92(6):639-641.
124. Saito H., Saito M., Saito K., et al. Subclinical pseudohypoparathyroidism type II: evidence for failure of physiologic adjustment in calcium metabolism during pregnancy. Am J Med Sci 1989, 297:247-250.
125. 3: biochemical characterization and production in normal subjects and patients with pseudohypoparathyroidism. J Clin Endocrinol Metab 1986, 62:192-196.
126. Glass E.J., Barr D.G. Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism. Arch Dis Child 1981, 56:565-568.
127. Nordin B.E., Roper A. Postpregnancy osteoporosis: a syndrome?. Lancet 1955, 268(6861):431-434.
128. Phillips A.J., Ostlere S.J., Smith R. Pregnancy-associated osteoporosis: does the skeleton recover?. Osteoporos Int 2000, 11(5):449-454.
129. Khovidhunkit W., Epstein S. Osteoporosis in pregnancy. Osteoporos Int 1996, 6(5):345-354.
130. Smith R., Athanasou N.A., Ostlere S.J., et al. Pregnancy-associated osteoporosis. QJM 1995, 88:865-878.
131. Reid I.R., Wattie D.J., Evans M.C., et al. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol (Oxf) 1992, 37:298-303.
132. Dunne F., Walters B., Marshall T., et al. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 1993, 39:487-490.
133. Ofluoglu O., Ofluoglu D. A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatol Int 2008, 29(2):197-201.
134. Lakhanpal S., Ginsburg W.W., Luthra H.S., et al. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 1987, 106(3):444-450.
135. Arayssi T.K., Tawbi H.A., Usta I.M., et al. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum 2003, 32(6):388-397.
136. Curtiss P.H., Kincaid W.E. Transitory demineralization of the hip in pregnancy: a report of three cases. J Bone Joint Surg Am 1959, 41:1327-1333.
137. Khastgir G., Studd J.W., King H., et al. Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis. Br J Obstet Gynaecol 1996, 103(7):716-718.
138. Kovacs C.S. Severe low bone mass partly rescued by normal pregnancy. J Bone Miner Res 2006, 21(Suppl 1):S310. [abstract].
139. Hellmeyer L., Boekhoff J., Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol 2010, 26(10):725-728.
140. Sarikaya S., Ozdolap S., Acikgoz G., et al. Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine 2004, 71(1):84-85.
141. Bayram S., Ozturk C., Sivrioglu K., et al. Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine 2006, 73(5):564-566.
142. Kim H.W., Song J.W., Kwon A., et al. Percutaneous vertebroplasty for pregnancy-associated osteoporotic vertebral compression fractures. J Korean Neurosurg Soc 2010, 47(5):399-402.
143. Kovacs C.S., El-Hajj Fuleihan G. Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 2006, 35(1):21-51.
144. Donovan E.F., Tsang R.C., Steichen J.J., et al. Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis. J Pediatr 1980, 96(2):305-310.
145. Cholst I.N., Steinberg S.F., Tropper P.J., et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984, 310(19):1221-1225.
146. Cruikshank D.P., Pitkin R.M., Reynolds W.A., et al. Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses. Am J Obstet Gynecol 1979, 134(3):243-249.
147. Koontz S.L., Friedman S.A., Schwartz M.L. Symptomatic hypocalcemia after tocolytic therapy with magnesium sulfate and nifedipine. Am J Obstet Gynecol 2004, 190(6):1773-1776.
148. Smith L.G., Burns P.A., Schanler R.J. Calcium homeostasis in pregnant women receiving long-term magnesium sulfate therapy for preterm labor. Am J Obstet Gynecol 1992, 167:45-51.
149. Hung J.W., Tsai M.Y., Yang B.Y., et al. Maternal osteoporosis after prolonged magnesium sulfate tocolysis therapy: a case report. Arch Phys Med Rehabil 2005, 86(1):146-149.
150. Levav A.L., Chan L., Wapner R.J. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report. Am J Perinatol 1998, 15(1):43-46.
151. Stone S.R., Pritchard J.A. Effect of maternally administered magnesium sulfate on the neonate. Obstet Gynecol 1970, 35(4):574-577.
152. Lipsitz P.J., English I.C. Hypermagnesemia in the newborn infant. Pediatrics 1967, 40(5):856-862.
153. Lipsitz P.J. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971, 47(3):501-509.
154. Savory J., Monif G.R. Serum calcium levels in cord sera of the progeny of mothers treated with magnesium sulfate for toxemia of pregnancy. Am J Obstet Gynecol 1971, 110(4):556-559.
155. Lamm C.I., Norton K.I., Murphy R.J., et al. Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr 1988, 113(6):1078-1082.
156. Santi M.D., Henry G.W., Douglas G.L. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994, 14(2):249-253.
157. Cumming W.A., Thomas V.J. Hypermagnesemia: a cause of abnormal metaphyses in the neonate. AJR Am J Roentgenol 1989, 152(5):1071-1072.
158. Malaeb S.N., Rassi A.I., Haddad M.C., et al. Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol 2004, 34(5):384-386.
159. Prentice A. Pregnancy and lactation. Pediatric bone: biology & diseases 2003, 249-269. Academic Press, New York. F.H. Glorieux, J.M. Petifor, H. Jüppner (Eds.).
160. Koo W.W., Walters J.C., Esterlitz J., et al. Maternal calcium supplementation and fetal bone mineralization. Obstet Gynecol 1999, 94(4):577-582.
161. Hofmeyr G.J., Atallah A.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2006, 3. CD001059.
162. Kumar A., Devi S.G., Batra S., et al. Calcium supplementation for the prevention of pre-eclampsia. Int J Gynaecol Obstet 2009, 104(1):32-36.
163. Hiller J.E., Crowther C.A., Moore V.A., et al. Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Aust N Z J Obstet Gynaecol 2007, 47(2):115-121.
164. Villar J., Abdel-Aleem H., Merialdi M., et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006, 194(3):639-649.
165. Prentice A. Calcium in pregnancy and lactation. Annu Rev Nutr 2000, 20:249-272.
166. Prentice A., Jarjou L.M., Cole T.J., et al. Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion. Am J Clin Nutr 1995, 62:58-67.
167. Prentice A., Jarjou L.M., Stirling D.M., et al. Biochemical markers of calcium and bone metabolism during 18 months of lactation in Gambian women accustomed to a low calcium intake and in those consuming a calcium supplement. J Clin Endocrinol Metab 1998, 83(4):1059-1066.
168. Prentice A., Yan L., Jarjou L.M., et al. Vitamin D status does not influence the breast-milk calcium concentration of lactating mothers accustomed to a low calcium intake. Acta Paediatr 1997, 86(9):1006-1008.
169. IOM Dietary reference intakes for calcium and vitamin D 2011, The National Academies Press, Washington, DC.
170. Bezerra F.F., Mendonca L.M., Lobato E.C., et al. Bone mass is recovered from lactation to postweaning in adolescent mothers with low calcium intakes. Am J Clin Nutr 2004, 80(5):1322-1326.
171. Chantry C.J., Auinger P., Byrd R.S. Lactation among adolescent mothers and subsequent bone mineral density. Arch Pediatr Adolesc Med 2004, 158(7):650-656.
172. Hillman L.S., Slatopolsky E., Haddad J.G. Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J Clin Endocrinol Metab 1978, 47:1073-1077.
173. Morley R., Carlin J.B., Pasco J.A., et al. Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J Clin Endocrinol Metab 2006, 91(3):906-912.
174. Ardawi M.S., Nasrat H.A., BA'Aqueel H.S. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 1997, 137(4):402-409.
175. Brooke O.G., Brown I.R., Bone C.D., et al. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 1980, 280:751-754.
176. Hollis B.W., Johnson D., Hulsey T.C., et al. Vitamin D supplementation during pregnancy: double blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011, [Epub ahead of print].
177. Wagner CL. Vitamin D supplementation during pregnancy: impact on maternal outcomes. Presented at the Centers for Disease Control and Prevention Conference on Vitamin D Physiology in Pregnancy: Implications for Preterm Birth and Preeclampsia. Atlanta (GA), April 26-7, 2011.
178. Glorieux F.H., St-Arnaud R. Vitamin D pseudodeficiency. Vitamin D 1997, 755-764. Academic Press, San Diego (CA). D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
179. Malloy P.J., Pike J.W., Feldman D. Hereditary 1,25-dihydroxyvitamin D resistant rickets. Vitamin D 1997, 765-787. Academic Press, San Diego (CA). D. Feldman, F.H. Glorieux, J.W. Pike (Eds.).
180. Wieland P., Fischer J.A., Trechsel U., et al. Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol 1980, 239:E385-E390.
181. Fleischman A.R., Rosen J.F., Cole J., et al. Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr 1980, 97:640-642.
182. Seki K., Furuya K., Makimura N., et al. Cord blood levels of calcium-regulating hormones and osteocalcin in premature infants. J Perinat Med 1994, 22:189-194.
183. Hollis B.W., Pittard W.B. Evaluation of the total fetomaternal vitamin D relationships at term: evidence for racial differences. J Clin Endocrinol Metab 1984, 59:652-657.
184. Viljakainen H.T., Saarnio E., Hytinantti T., et al. Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab 2010, 95(4):1749-1757.
185. Halloran B.P., De Luca H.F. Effect of vitamin D deficiency on skeletal development during early growth in the rat. Arch Biochem Biophys 1981, 209:7-14.
186. Miller S.C., Halloran B.P., DeLuca H.F., et al. Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int 1983, 35:455-460.
187. Lachenmaier-Currle U., Harmeyer J. Placental transport of calcium and phosphorus in pigs. J Perinat Med 1989, 17:127-136.
188. Panda D.K., Miao D., Tremblay M.L., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001, 98(13):7498-7503.
189. Dardenne O., Prud'homme J., Arabian A., et al. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142(7):3135-3141.
190. Li Y.C., Amling M., Pirro A.E., et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 1998, 139(10):4391-4396.
191. Li Y.C., Pirro A.E., Amling M., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 1997, 94:9831-9835.
192. Halloran B.P., DeLuca H.F. Calcium transport in small intestine during early development: role of vitamin D. Am J Physiol 1980, 239:G473-G479.
193. Ghishan F.K., Parker P., Nichols S., et al. Kinetics of intestinal calcium transport during maturation in rats. Pediatr Res 1984, 18:235-239.
194. Ghishan F.K., Jenkins J.T., Younoszai M.K. Maturation of calcium transport in the rat small and large intestine. J Nutr 1980, 110:1622-1628.
195. Amling M., Priemel M., Holzmann T., et al. Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140(11):4982-4987.
196. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A 2001, 98(23):13324-13329.
197. Dardenne O., Prudhomme J., Hacking S.A., et al. Rescue of the pseudo-vitamin D deficiency rickets phenotype of CYP27B1-deficient mice by treatment with 1,25-dihydroxyvitamin D3: biochemical, histomorphometric, and biomechanical analyses. J Bone Miner Res 2003, 18(4):637-643.
198. Rowling M.J., Gliniak C., Welsh J., et al. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 2007, 137(12):2608-2615.
199. Hoenderop J.G., Dardenne O., Van Abel M., et al. Modulation of renal Ca2+ transport protein genes by dietary Ca2+ and 1,25-dihydroxyvitamin D3 in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice. FASEB J 2002, 16(11):1398-1406.
200. Maxwell J.P., Miles L.M. Osteomalacia in China. J Obstet Gynaecol Br Empire 1925, 32(3):433-473.
201. Campbell D.E., Fleischman A.R. Rickets of prematurity: controversies in causation and prevention. Clin Perinatol 1988, 15:879-890.
202. Pereira G.R., Zucker A.H. Nutritional deficiencies in the neonate. Clin Perinatol 1986, 13:175-189.
203. Specker B.L. Do North American women need supplemental vitamin D during pregnancy or lactation?. Am J Clin Nutr 1994, 59:484S-490S.
204. Beck-Nielsen S.S., Brock-Jacobsen B., Gram J., et al. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 2009, 160(3):491-497.
205. Teotia M., Teotia S.P., Nath M. Metabolic studies in congenital vitamin D deficiency rickets. Indian J Pediatr 1995, 62(1):55-61.
206. Ward L.M., Gaboury I., Ladhani M., et al. Vitamin D-deficiency rickets among children in Canada. CMAJ 2007, 177(2):161-166.
207. Ashraf A., Mick G., Atchison J., et al. Prevalence of hypovitaminosis D in early infantile hypocalcemia. J Pediatr Endocrinol Metab 2006, 19(8):1025-1031.
208. Teaema F.H., Al Ansari K. Nineteen cases of symptomatic neonatal hypocalcemia secondary to vitamin D deficiency: a 2-year study. J Trop Pediatr 2010, 56(2):108-110.
209. Cranney A., Horsley T., O'Donnell S., et al. Effectiveness and Safety of Vitamin D in Relation to Bone Health. Evidence Report/Technology Assessment No. 158 2007, AHRQ Publication No. 07-E013, Agency for Healthcare Research and Quality, Rockville (MD).
210. Pettifor J.M. Vitamin D &/or calcium deficiency rickets in infants & children: a global perspective. Indian J Med Res 2008, 127(3):245-249.
211. Thacher T.D., Fischer P.R., Pettifor J.M., et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. N Engl J Med 1999, 341(8):563-568.
212. Fischer P.R., Rahman A., Cimma J.P., et al. Nutritional rickets without vitamin D deficiency in Bangladesh. J Trop Pediatr 1999, 45(5):291-293.
213. Thacher T.D., Obadofin M.O., O'Brien K.O., et al. The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets. J Clin Endocrinol Metab 2009, 94(9):3314-3321.
214. Rauch F. Etiology and treatment of hypocalcemic rickets in children. UpToDate 17.3 2009, UpToDate, Wellesley (MA). B.D. Rose (Ed.).
215. Bouillon R., Verstuyf A., Mathieu C., et al. Vitamin D resistance. Best Pract Res Clin Endocrinol Metab 2006, 20(4):627-645.
216. Takeda E., Yamamoto H., Taketani Y., et al. Vitamin D-dependent rickets type I and type II. Acta Paediatr Jpn 1997, 39(4):508-513.
217. Kitanaka S., Takeyama K., Murayama A., et al. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 1998, 338(10):653-661.
218. Silver J., Landau H., Bab I., et al. Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy. Isr J Med Sci 1985, 21(1):53-56.
219. Teotia M., Teotia S.P. Nutritional and metabolic rickets. Indian J Pediatr 1997, 64(2):153-157.
220. Balsan S., Garabedian M., Larchet M., et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 1986, 77(5):1661-1667.
221. Hochberg Z., Tiosano D., Even L. Calcium therapy for calcitriol-resistant rickets. J Pediatr 1992, 121(5 Pt 1):803-808.
222. Javaid M.K., Crozier S.R., Harvey N.C., et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367(9504):36-43.
223. Cooper C., Westlake S., Harvey N., et al. Review: developmental origins of osteoporotic fracture. Osteoporos Int 2006, 17(3):337-347.
224. Mahon P., Harvey N., Crozier S., et al. Low maternal vitamin D status and fetal bone development: cohort study. J Bone Miner Res 2010, 25(1):14-19.
225. Kent G.N., Price R.I., Gutteridge D.H., et al. Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaning. J Bone Miner Res 1990, 5:361-369.
226. Sowers M., Zhang D., Hollis B.W., et al. Role of calciotrophic hormones in calcium mobilization of lactation. Am J Clin Nutr 1998, 67(2):284-291.
227. Hollis B.W., Wagner C.L. Vitamin D requirements during lactation: high-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004, 80(Suppl 6):1752S-1758S.
228. Rothberg A.D., Pettifor J.M., Cohen D.F., et al. Maternal-infant vitamin D relationships during breast-feeding. J Pediatr 1982, 101(4):500-503.
229. Ala-Houhala M., Koskinen T., Parviainen M.T., et al. 25-Hydroxyvitamin D and vitamin D in human milk: effects of supplementation and season. Am J Clin Nutr 1988, 48(4):1057-1060.
230. Ala-Houhala M. 25-Hydroxyvitamin D levels during breast-feeding with or without maternal or infantile supplementation of vitamin D. J Pediatr Gastroenterol Nutr 1985, 4(2):220-226.
231. Greer F.R., Searcy J.E., Levin R.S., et al. Bone mineral content and serum 25-hydroxyvitamin D concentrations in breastfed infants with and without supplemental vitamin D: one-year follow-up. J Pediatr 1982, 100(6):919-922.
232. Greer F.R., Marshall S. Bone mineral content, serum vitamin D metabolite concentrations, and ultraviolet B light exposure in infants fed human milk with and without vitamin D2 supplements. J Pediatr 1989, 114(2):204-212.
233. Halloran B.P., DeLuca H.F. Skeletal changes during pregnancy and lactation: the role of vitamin D. Endocrinology 1980, 107:1923-1929.
234. Miller S.C., Halloran B.P., DeLuca H.F., et al. Role of vitamin D in maternal skeletal changes during pregnancy and lactation: a histomorphometric study. Calcif Tissue Int 1982, 34:245-252.
235. Basile L.A., Taylor S.N., Wagner C.L., et al. The effect of high-dose vitamin D supplementation on serum vitamin D levels and milk calcium concentration in lactating women and their infants. Breastfeed Med 2006, 1(1):27-35.
236. Wagner C.L., Hulsey T.C., Fanning D., et al. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med 2006, 1(2):59-70.
237. Hollis B.W., Wagner C.L. Assessment of dietary vitamin D requirements during pregnancy and lactation. Am J Clin Nutr 2004, 79(5):717-726.
238. Usta I.M., Chammas M., Khalil A.M. Renal cell carcinoma with hypercalcemia complicating a pregnancy: case report and review of the literature. Eur J Gynaecol Oncol 1998, 19(6):584-587.
239. Illidge T.M., Hussey M., Godden C.W. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate. Clin Oncol (R Coll Radiol) 1996, 8(4):257-258.
240. Montoro M.N., Paler R.J., Goodwin T.M., et al. Parathyroid carcinoma during pregnancy. Obstet Gynecol 2000, 96(5 Pt 2):841.
241. Abraham P., Ralston S.H., Hewison M., et al. Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure. Postgrad Med J 2002, 78(926):752-753.
242. Hwang C.S., Park S.Y., Yu S.H., et al. Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy. Gynecol Oncol 2006, 103(2):740-744.
243. Culbert E.C., Schfirin B.S. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions. Obstet Gynecol 2006, 108(3 Pt 2):789-791.
244. McCormick T.C., Muffly T., Lu G., et al. Aggressive small cell carcinoma of the ovary, hypercalcemic type with hypercalcemia in pregnancy, treated with conservative surgery and chemotherapy. Int J Gynecol Cancer 2009, 19(8):1339-1341.